• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在鬼臼毒素相关的继发性急性髓系白血病中被破坏的ALL-1基因的共同区域。

Common region of ALL-1 gene disrupted in epipodophyllotoxin-related secondary acute myeloid leukemia.

作者信息

Felix C A, Winick N J, Negrini M, Bowman W P, Croce C M, Lange B J

机构信息

Department of Pediatrics, Children's Hospital of Philadelphia, Pennsylvania 19104.

出版信息

Cancer Res. 1993 Jul 1;53(13):2954-6.

PMID:8319201
Abstract

Translocations at chromosomal band 11q23 characterize most de novo acute lymphoblastic leukemias (ALL) of infants, acute myeloid leukemias (AML) of infants and young children, and secondary AMLs following epipodophyllotoxin exposure. The chromosomal breakpoints at 11q23 have been cloned from isolated cases of de novo ALL and AML. Using an 859-base pair BamHI fragment of human ALL-1 complementary DNA that recognizes the genomic breakpoint region for de novo ALL and AML, we investigated two cases of secondary AML that followed etoposide-treated primary B-lineage ALL. In the first case, the translocation occurred between chromosomes 9 and 11 and the breakpoint at 11q23 localized to the same 9-kilobase region of the ALL-1 gene that is disrupted in most of the de novo leukemias. In the second case the translocation was between chromosomes 11 and 19. The breakpoint occurred outside of the ALL-1 breakpoint cluster region.

摘要

位于染色体带11q23的易位是大多数婴儿新发急性淋巴细胞白血病(ALL)、婴幼儿急性髓细胞白血病(AML)以及接触表鬼臼毒素后继发性AML的特征。已从新发ALL和AML的个别病例中克隆出11q23处的染色体断点。利用人ALL-1互补DNA的一个859碱基对的BamHI片段(该片段可识别新发ALL和AML的基因组断点区域),我们研究了两例继发于依托泊苷治疗的原发性B系ALL后的继发性AML病例。在第一例中,易位发生在9号和11号染色体之间,11q23处的断点定位于ALL-1基因的同一个9千碱基区域,该区域在大多数新发白血病中被破坏。在第二例中,易位发生在11号和19号染色体之间。断点出现在ALL-1断点簇区域之外。

相似文献

1
Common region of ALL-1 gene disrupted in epipodophyllotoxin-related secondary acute myeloid leukemia.在鬼臼毒素相关的继发性急性髓系白血病中被破坏的ALL-1基因的共同区域。
Cancer Res. 1993 Jul 1;53(13):2954-6.
2
Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations.伴有11q23染色体易位的急性淋巴细胞白血病和急性髓细胞白血病中MLL基因的重排。
N Engl J Med. 1993 Sep 23;329(13):909-14. doi: 10.1056/NEJM199309233291302.
3
Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites.11q23断点在初发急性白血病和治疗相关急性髓系白血病的MLL断点簇区域内的分布:与支架附着区域和拓扑异构酶II共有结合位点的相关性
Blood. 1996 Mar 1;87(5):1912-22.
4
11q23 aberration is an additional chromosomal change in de novo acute leukemia after treatment with etoposide and mitoxantrone.11q23畸变是依托泊苷和米托蒽醌治疗后新发急性白血病中额外的染色体改变。
Am J Hematol. 1996 Dec;53(4):264-6. doi: 10.1002/(SICI)1096-8652(199612)53:4<264::AID-AJH12>3.0.CO;2-C.
5
Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocations.急性髓系白血病中ALL-1基因的分子重排,无11q23染色体易位的细胞遗传学证据。
Cancer Res. 1994 Jan 15;54(2):370-3.
6
[Chromosome translocations and leukemias induced by inhibitors of topoisomerase II anticarcinogenic drugs].[拓扑异构酶II抗癌药物抑制剂诱导的染色体易位与白血病]
Bull Cancer. 1998 Mar;85(3):254-61.
7
Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks.鬼臼毒素治疗后相关的急性髓系白血病:风险评估
Med Pediatr Oncol. 1994;23(2):86-98. doi: 10.1002/mpo.2950230205.
8
Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia.接受鬼臼毒素治疗急性淋巴细胞白血病的儿童中的急性髓系白血病。
N Engl J Med. 1991 Dec 12;325(24):1682-7. doi: 10.1056/NEJM199112123252402.
9
Distinct MLL gene rearrangements associated with successive acute monocytic and lymphoblastic leukemias in the same patient.
Leukemia. 1994 Dec;8(12):2224-7.
10
[Secondary leukemia after etoposide treatment involved MLL gene rearrangement].依托泊苷治疗后发生的继发性白血病涉及混合谱系白血病基因重排
Rinsho Ketsueki. 1994 Jun;35(6):569-75.

引用本文的文献

1
DNA topoisomerase II, genotoxicity, and cancer.DNA拓扑异构酶II、遗传毒性与癌症。
Mutat Res. 2007 Oct 1;623(1-2):83-97. doi: 10.1016/j.mrfmmm.2007.06.009. Epub 2007 Jul 3.
2
Early G2/M checkpoint failure as a molecular mechanism underlying etoposide-induced chromosomal aberrations.早期G2/M期检查点功能障碍作为依托泊苷诱导染色体畸变的分子机制。
J Clin Invest. 2006 Jan;116(1):80-9. doi: 10.1172/JCI25716. Epub 2005 Dec 15.
3
The amino terminus of the mixed lineage leukemia protein (MLL) promotes cell cycle arrest and monocytic differentiation.
混合谱系白血病蛋白(MLL)的氨基末端可促进细胞周期停滞和单核细胞分化。
Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2797-802. doi: 10.1073/pnas.040574897.
4
Association of CYP3A4 genotype with treatment-related leukemia.细胞色素P450 3A4(CYP3A4)基因分型与治疗相关白血病的关联
Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13176-81. doi: 10.1073/pnas.95.22.13176.
5
The oncogenic capacity of HRX-ENL requires the transcriptional transactivation activity of ENL and the DNA binding motifs of HRX.HRX-ENL的致癌能力需要ENL的转录反式激活活性以及HRX的DNA结合基序。
Mol Cell Biol. 1998 Jan;18(1):122-9. doi: 10.1128/MCB.18.1.122.
6
Panhandle PCR strategy to amplify MLL genomic breakpoints in treatment-related leukemias.用于扩增治疗相关白血病中MLL基因座断点的柄式PCR策略。
Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11583-8. doi: 10.1073/pnas.94.21.11583.
7
Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): a report from the Children's Cancer Group.母亲接触DNA拓扑异构酶II潜在抑制剂与婴儿白血病(美国):儿童癌症研究组的报告
Cancer Causes Control. 1996 Nov;7(6):581-90. doi: 10.1007/BF00051700.
8
Pharmacodynamics and long-term toxicity of etoposide.
Cancer Chemother Pharmacol. 1994;34 Suppl:S64-8. doi: 10.1007/BF00684866.